|Basic InformationMore InformationTestsLatest News|Studies Question Link Between Mom's Antidepressant Use, Autism in KidsMortality Up With Depression Just Before Breast Cancer DiagnosisDepressive Disorders Up With Antimuscarinics for OABTrauma as a Teen May Boost Depression Risk Around MenopauseBlood Test Promising for ID of Early Depression, SchizophreniaBlood Test Might Someday Distinguish Early Depression, SchizophreniaHold That Pose: Yoga May Ease Tough DepressionDepression May Hasten Death in Years After Heart DiagnosisAntidepressant Efficacy Varies for Depressive Symptom ClustersDepressed Psoriasis Patients at Higher Risk of Psoriatic ArthritisInternet-Based CBT Effective for Depressive SymptomsCan Depression Up Odds for Arthritis Linked to Psoriasis?Postpartum Depressive Symptoms Fell in 2004 to 2012Hey Fellas, Depression Can Strike New Dads, TooDepression Often Untreated in Dialysis PatientsGDM Found to Increase Risk for Postpartum DepressionPostpartum Depression Affects New Dads, TooPanic Disorder May Up Odds of Depression Rx Side EffectsSometimes the Holidays Aren't Always JollyPilots Suffer Depression, Suicidal Thoughts at Fairly High RatesMore Than 1 in 10 Pilots Suffer From Depression, Survey FindsSelf-Care Tools Cut Depression in AMD, Diabetic RetinopathyClinical Antecedents of Adolescent-Onset MDD IdentifiedAge-Related Cataract Linked to Depressive SymptomsDepression, Suicide Ideation Prevalent in Medical Students2 Out of 3 Depressed Teens Gain Lasting Benefits From TherapyAntidepressants + Exercise Beneficial in Late-Life DepressionDepressed Women Less Likely to Get Best Breast Cancer Care: StudyDepression on the Rise Among U.S. Teens, Especially GirlsMemantine + Sertraline Effective for Major Depressive DisorderDepressive Symptoms Linked to Functional Status in CADHigh Rate of Antidepressant Use After CancerResearchers Find Antidepressant Bupropion Crosses PlacentaSome Antihypertensives Linked to Depression, Bipolar RiskMom-to-Be's Antidepressant Use May Be Tied to Speech Issues in ChildDepression Can Fuel Heart Disease in Midlife Women: StudyDepression Common in Patients With Chronic Angina'The Pill' May Raise Depression RiskFacebook Bullying Can Cause DepressionStroke Survivors Often Struggle With DepressionMany Cases of Depression in Adults Not Being TreatedMany Depressed Adults Not Getting Treatment: StudyMajor Depressive Disorder Ups Acute MI Risk in HIV-InfectedPostpartum Depression Can Be ID'd During Infant HospitalizationDepression Common After Time Spent in ICUStudy Finds Links Between Chronic Pain, Depression in CouplesDepression Can Stalk Families Through GenerationsScientists Spot 15 Regions of Human DNA Linked to DepressionBehavioral Activation Therapy Viable Option in DepressionCould New 'Talk Therapy' Cut Cost of Treating Depression?Questions and AnswersLinks
Depressive Disorders Up With Antimuscarinics for OAB
Updated: Apr 12th 2017
WEDNESDAY, April 12, 2017 (HealthDay News) -- Women with overactive bladder (OAB) syndrome treated with antimuscarinics have increased subsequent risk of depressive disorder, according to a study published online April 5 in the Journal of Clinical Pharmacology.
Shiu-Dong Chung, Ph.D., M.D., from the Far Eastern Memorial Hospital in Taiwan, and colleagues conducted a retrospective cohort study to examine the correlation between antimuscarinic use and subsequent risk of depressive disorder. Data were obtained from the Taiwan Longitudinal Health Insurance Database 2005 for 1,952 women with OAB who received antimuscarinics and 9,760 who did not receive antimuscarinics. The women were followed for three years from the index date.
The researchers found that the adjusted hazard ratio for depressive disorder was 1.38 (95 percent confidence interval, 1.15 to 1.64) for women with OAB who received antimuscarinics versus those who did not receive antimuscarinics. For women with OAB aged 18 to 39, 40 to 59, and ≥60 years who received antimuscarinics, the adjusted hazard ratios for subsequent depressive disorder were 1.83 (95 percent confidence interval, 1.27 to 2.64), 1.36 (95 percent confidence interval, 1.03 to 1.81), and 1.16 (95 percent confidence interval, 0.86 to 1.56), respectively.
"Clinicians should be alert to the relationship between antimuscarinics usage and depressive disorder in OAB women and provide appropriate instructions for these patients," the authors write.
This article: Copyright © 2017 HealthDay. All rights reserved.